Visual hallucinations and unusual pain related to hypomagnesemia in an advanced cancer patient
DOI:
https://doi.org/10.23938/ASSN.0560Keywords:
Neurotoxicidad. Opiáceo. Hipomagnesemia. Alucinación. Dolor.Abstract
Hypomagnesemia has been related to high accumulated doses of cisplatin, and its clinical presence is characterized by neuromuscular and cardiovascular alterations. We present the case of an advanced cancer patient who had received successive lines of chemotherapy and who was receiving opioid treatment for cancer pain. During his hospital stay, he experienced visual hallucinations and very intense, unexplained pain in one shoulder. Symptoms reverted with the normalization of his plasma magnesium levels, which were low. We consider that plasma magnesium levels should be monitored in oncology patients with neurological or psychiatric symptoms or with unusual pain.Downloads
References
1. HASHIZUME N, MORI M. An analysis of hypermagnesemia and hypomagnesemia. Jpn J Med 1990; 29: 368-372.
https://doi.org/10.2169/internalmedicine1962.29.368
2. SCHIMATSCHEK HF, REMPIS R. Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes Res 2001; 14: 283-290.
3. LAJER H, DAUGAARD G. Cisplatin and hypomagnesemia. Cancer Treat Rev 1999; 25: 47-58.
https://doi.org/10.1053/ctrv.1999.0097
4. ARICETA G, RODRÍGUEZ-SORIANO J, VALLO A, NAVAJAS A. Acute and chronic effects of cisplatin therapy on renal magnesium homeostasis. Med Pediatr Oncol 1997; 28: 35-40.
https://doi.org/10.1002/(SICI)1096-911X(199701)28:1<35::AID-MPO7>3.0.CO;2-U
5. MAVICHAK V, COPPIN CM, WONG NL, DIRKS JH, WALKER V, SUTTON RA. Renal magnesium wasting and hypocalciuria in chronic cis-platinum nephropathy in man. Clin Sci (Lond) 1988; 75: 203-207.
https://doi.org/10.1042/cs0750203
6. COJOCARU IM, COJOCARU M, TĂNĂSESCU R, IACOB SA, ILIESCU I. Changes of magnesium serum levels in patients with acute ischemic stroke and acute infections. Rom J Intern Med 2009; 47: 169-171.
7. SAIF MW. Management of hypomagnesemia in cancer patients receiving chemotherapy. J Support Oncol 2008; 6: 243-248.
8. VELLA-BRINCAT J, MACLEOD AD. Adverse effects of opioids on the central nervous systems of palliative care patients. J Pain Palliat Care Pharmacother 2007; 21: 15-25.
https://doi.org/10.1080/J354v21n01_05
9. DE STOUTZ ND, BRUERA E, SUAREZ-ALMAZOR M. Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 1995; 10: 378-384.
https://doi.org/10.1016/0885-3924(95)90924-C
10. AGUS ZS. Hypomagnesemia. J Am Soc Nephrol 1999; 10: 1616-1622.
https://doi.org/10.1681/ASN.V1071616
11. BUJALSKA M, MALINOWSKA E, MAKULSKA-NOWAK H, GUMULKA SW. Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia. Pharmacology 2008; 82: 180-186.
https://doi.org/10.1159/000151346
12. MERT T, GUNES Y, OZCENGIZ D, GUNAY I. Magnesium modifies fentanyl-induced local antinociception and hyperalgesia. Naunyn Schmiedebergs Arch Pharmacol 2009; 380: 415-420.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
